https://www.hospitalhealth.com.au/content/clinical-services/news/rsv-prevention-could-be-be-within-reach-research-1091113111
0
0
30 words
0
Comments
Immunisations providing protection against deadly respiratory syncytial virus (RSV) could be accessible on the market within 12 months.
You are the first to view
Create an account or login to join the discussion